• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Myc赋予前列腺癌细胞雄激素非依赖性生长能力。

Myc confers androgen-independent prostate cancer cell growth.

作者信息

Bernard David, Pourtier-Manzanedo Albin, Gil Jesús, Beach David H

机构信息

Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, United Kindom.

出版信息

J Clin Invest. 2003 Dec;112(11):1724-31. doi: 10.1172/JCI19035.

DOI:10.1172/JCI19035
PMID:14660748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC281646/
Abstract

Prostate cancer is one of the most diagnosed and mortal cancers in western countries. A major clinical problem is the development of androgen-independent prostate cancer (AIPC) during antihormonal treatment. The molecular mechanisms underlying the change from androgen dependence to independence of these tumors are poorly understood and represent a challenge to develop new therapies. Based on genetic data showing amplification of the c-myc gene in AIPC, we studied the ability of c-myc to confer AIPC cell growth. Human androgen-dependent prostate cancer cells overexpressing c-myc grew independently of androgens and presented tumorigenic properties in androgen-depleted conditions. Analysis of signalling pathways by pharmacological inhibitors of the androgen receptor (AR) or by RNA interference directed against AR or c-myc showed that c-myc acted downstream of AR through multiple growth effectors. Thus c-myc is required for androgen-dependent growth and following ectopic expression can induce androgen-independent growth. Moreover, RNA interference directed against c-myc showed that growth of human AIPC cells, AR-positive or -negative, required c-myc expression. Furthermore, we showed that c-myc-overexpressing cells retain a functional p53 pathway and thus respond to etoposide.

摘要

前列腺癌是西方国家诊断率和死亡率最高的癌症之一。一个主要的临床问题是在抗激素治疗期间发生雄激素非依赖性前列腺癌(AIPC)。这些肿瘤从雄激素依赖性转变为非依赖性的分子机制尚不清楚,这对开发新疗法构成了挑战。基于显示AIPC中c-myc基因扩增的基因数据,我们研究了c-myc赋予AIPC细胞生长的能力。过表达c-myc的人雄激素依赖性前列腺癌细胞在无雄激素的情况下独立生长,并在雄激素缺乏的条件下呈现致瘤特性。通过雄激素受体(AR)的药理学抑制剂或针对AR或c-myc的RNA干扰对信号通路进行分析表明,c-myc通过多种生长效应器作用于AR的下游。因此,c-myc是雄激素依赖性生长所必需的,异位表达后可诱导雄激素非依赖性生长。此外,针对c-myc的RNA干扰表明,人AIPC细胞(无论AR阳性或阴性)的生长都需要c-myc表达。此外,我们还表明,过表达c-myc的细胞保留了功能性p53通路,因此对依托泊苷有反应。

相似文献

1
Myc confers androgen-independent prostate cancer cell growth.Myc赋予前列腺癌细胞雄激素非依赖性生长能力。
J Clin Invest. 2003 Dec;112(11):1724-31. doi: 10.1172/JCI19035.
2
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.前列腺癌细胞中的雄激素受体信号传导与维生素D受体作用
Prostate. 2005 Sep 1;64(4):362-72. doi: 10.1002/pros.20251.
3
Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.通过对一种新型小鼠前列腺癌细胞系的表征揭示的上下文依赖性激素难治性进展
Cancer Res. 2005 Dec 15;65(24):11565-71. doi: 10.1158/0008-5472.CAN-05-3441.
4
PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.早幼粒细胞白血病锌指蛋白调控前B细胞白血病转录因子1的转录,且前B细胞白血病转录因子1-同源盒基因C8复合物导致雄激素非依赖性前列腺癌增殖。
Prostate. 2006 Jul 1;66(10):1092-9. doi: 10.1002/pros.20443.
5
Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.雄激素受体过度激活会导致前列腺癌细胞的雄激素非依赖性生长。
J Mol Endocrinol. 2008 Jul;41(1):13-23. doi: 10.1677/JME-07-0158. Epub 2008 May 9.
6
Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.雄激素受体非基因组信号的变化与LNCaP细胞向雄激素非依赖性的转变相关。
Cancer Res. 2004 Oct 1;64(19):7156-68. doi: 10.1158/0008-5472.CAN-04-1121.
7
Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).Id-1表达通过激活表皮生长因子受体(EGF-R)诱导雄激素非依赖性前列腺癌细胞生长。
Carcinogenesis. 2004 Apr;25(4):517-25. doi: 10.1093/carcin/bgh047. Epub 2003 Dec 19.
8
Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.普遍存在的线粒体肌酸激酶在LNCaP谱系雄激素非依赖性细胞系的条件培养基和提取物中过表达,并促进前列腺癌进展。
Prostate. 2009 Aug 1;69(11):1176-87. doi: 10.1002/pros.20969.
9
5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.5α-雄甾烷-3α,17β-二醇通过雄激素受体非依赖性信号通路支持人前列腺癌细胞的存活和增殖:雄激素非依赖性前列腺癌进展的意义。
J Cell Biochem. 2008 Aug 1;104(5):1612-24. doi: 10.1002/jcb.21731.
10
The role of c-Jun and c-Fos expression in androgen-independent prostate cancer.c-Jun和c-Fos表达在雄激素非依赖性前列腺癌中的作用。
J Pathol. 2004 Oct;204(2):153-8. doi: 10.1002/path.1605.

引用本文的文献

1
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.Neurog2在MYCN驱动的前列腺癌神经内分泌可塑性中的新作用。
Oncogene. 2025 Apr 29. doi: 10.1038/s41388-025-03413-0.
2
Advances in tumor subclone formation and mechanisms of growth and invasion.肿瘤亚克隆形成以及生长和侵袭机制的进展
J Transl Med. 2025 Apr 21;23(1):461. doi: 10.1186/s12967-025-06486-3.
3
Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer.细胞周期蛋白依赖性激酶作为前列腺癌异常转录的介质
Transl Oncol. 2025 May;55:102378. doi: 10.1016/j.tranon.2025.102378. Epub 2025 Mar 30.
4
Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer.转移性去势敏感性前列腺癌中致癌基因驱动因素的格局及预后意义
Transl Cancer Res. 2024 Nov 30;13(11):6235-6245. doi: 10.21037/tcr-24-123. Epub 2024 Oct 14.
5
CDK12-inactivation-induced MYC signaling causes dependency on the splicing kinase SRPK1.CDK12 失活诱导的 MYC 信号导致对剪接激酶 SRPK1 的依赖性。
Mol Oncol. 2024 Oct;18(10):2510-2523. doi: 10.1002/1878-0261.13666. Epub 2024 May 22.
6
Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions.解析前列腺癌中 8q24-MYC 基因座的转录,认识到雄激素受体直接和间接双重功能之间的平衡。
J Transl Med. 2023 Oct 12;21(1):716. doi: 10.1186/s12967-023-04429-4.
7
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.MYC 是雄激素受体抑制诱导前列腺癌代谢需求的调节因子。
Cell Rep. 2023 Oct 31;42(10):113221. doi: 10.1016/j.celrep.2023.113221. Epub 2023 Oct 9.
8
Generating a Murine PTEN Null Cell Line to Discover the Key Role of p110β-PAK1 in Castration-Resistant Prostate Cancer Invasion.生成小鼠 PTEN 基因敲除细胞系以探索 p110β-PAK1 在去势抵抗性前列腺癌侵袭中的关键作用。
Mol Cancer Res. 2023 Dec 1;21(12):1317-1328. doi: 10.1158/1541-7786.MCR-22-0808.
9
Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer.雄激素受体和 MYC 转录组在前列腺癌的多层调控回路中达到平衡。
Prostate. 2023 Nov;83(15):1415-1429. doi: 10.1002/pros.24603. Epub 2023 Aug 11.
10
Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis.8q 染色体臂过表达与前列腺癌预后不良相关。
Urol Oncol. 2023 Feb;41(2):106.e17-106.e23. doi: 10.1016/j.urolonc.2022.10.002. Epub 2022 Nov 15.

本文引用的文献

1
Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.雄激素受体抑制前列腺癌细胞中的神经内分泌转分化过程。
Mol Endocrinol. 2003 Sep;17(9):1726-37. doi: 10.1210/me.2003-0031. Epub 2003 May 29.
2
Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer.激素难治性前列腺癌骨转移灶中雄激素受体基因的扩增
J Pathol. 2002 Oct;198(2):237-44. doi: 10.1002/path.1206.
3
A history of prostate cancer treatment.前列腺癌治疗史。
Nat Rev Cancer. 2002 May;2(5):389-96. doi: 10.1038/nrc801.
4
Androgen ablation promotes neuroendocrine cell differentiation in dog and human prostate.
Prostate. 2002 May 1;51(2):117-25. doi: 10.1002/pros.10066.
5
The development of androgen-independent prostate cancer.雄激素非依赖性前列腺癌的发展。
Nat Rev Cancer. 2001 Oct;1(1):34-45. doi: 10.1038/35094009.
6
Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.前列腺癌中雌激素、孕激素和雄激素受体的甲基化与失活
J Natl Cancer Inst. 2002 Mar 6;94(5):384-90. doi: 10.1093/jnci/94.5.384.
7
Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy.神经内分泌分化的小细胞癌表现为雄激素剥夺治疗后复发的前列腺癌。
BJU Int. 2001 Dec;88(9):982-3. doi: 10.1046/j.1464-4096.2001.00936.x.
8
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.前列腺癌中ERBB2癌基因的表达及基因拷贝数分析
Am J Pathol. 2002 Jan;160(1):339-45. doi: 10.1016/S0002-9440(10)64377-5.
9
Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer.雄激素受体的扩增可能无法解释雄激素非依赖性前列腺癌的发生发展。
BJU Int. 2001 Oct;88(6):633-7. doi: 10.1046/j.1464-410x.2001.02350.x.
10
Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line.雄激素诱导人乳头瘤病毒16 E6/E7永生化前列腺上皮细胞系分化。
J Endocrinol. 2001 Jul;170(1):287-96. doi: 10.1677/joe.0.1700287.